Armenia · Clinics, agencies, contracts and payments

Editorial still life of contract papers and a payment checklist beside a calculator
Editorial illustration only; it is not evidence of a real clinic, contract, licence or approval.

Armenia Surrogacy: Contracts, Agencies and Payments — Legal Rules and Risks

Bottom line and governing law

Armenia does permit surrogacy, but a contract is not a universal permission slip. The arrangement depends on the intended parent's legal eligibility, the surrogate's statutory eligibility, a written notarized agreement, licensed reproductive medical care, and a payment plan that follows the statute. A clinic or agency's marketing statement is not proof that the specific family, surrogate, embryo arrangement, or cross-border plan is lawful. Confirm those facts before transferring a non-refundable fee or starting treatment.

The core rules are in Armenia's Law on Human Reproductive Health and Reproductive Rights, especially Articles 11–19 in the current consolidated Armenian text, which reflects amendments effective in December 2025. Article 19 expressly requires services involving assisted reproductive technologies to be provided by healthcare institutions licensed for the relevant type of medical aid and service. The law regulates permitted embryo-transfer routes, the parties' agreements, compensation, health duties, DNA testing, and confidentiality. The official Armenian text controls; translations are reading aids and do not replace checking the current Armenian wording.

Who may use surrogacy

The general rules for assisted reproductive technologies recognize married couples and unmarried individuals, but surrogacy-specific restrictions narrow that wording. The law excludes an unmarried man who will not be the child's biological parent; excludes a woman who has no medical contraindication to carrying a pregnancy; and excludes a foreign national who is not ethnically Armenian from using an Armenian-citizen surrogate. If the intended parent(s) will not be the child's biological parent(s), Article 12(1.2) requires permission from an interdepartmental commission and limits this route to the categories listed in the law: Armenian-citizen married couples and unmarried women, plus legally present Armenian-ethnicity foreign married couples or unmarried women who provide acceptable proof of Armenian ethnicity. Do not assume a foreign applicant qualifies just because a clinic accepts an inquiry; confirm the facts and permit route in writing.

On 1 April 2025, Armenia's Constitutional Court held the age limits in Article 12(1)(1) and (2) unconstitutional to the extent that they restricted access to assisted reproductive technologies by age. Law HO-404-N, effective 20 December 2025, then removed the 55-year and 53-year wording from Article 12(1). The current consolidated text no longer sets those age caps for intended ART users. This does not remove the separate surrogacy restrictions in Article 12(1.1)–(1.2), including the medical-contraindication, nationality/ethnicity and interdepartmental-commission rules, or the separate surrogate criteria in Article 15. Obtain a current written eligibility assessment for the specific family and treatment plan.

Surrogate eligibility and notarized agreement

Article 15 generally allows a surrogate aged 20–38 who has at least one child, has given birth no more than three times, has had no more than one caesarean delivery, and passes the required medical examination without contraindications. A special route exists for a woman carrying an embryo provided by relatives: she must be of reproductive age from 20 and have previously given birth at least once, and must pass the required medical-genetic examination. A woman in a marriage registered under Armenian law needs her husband's consent. A woman with a listed medical contraindication or who has already acted as a surrogate at least twice is ineligible; the surrogate cannot also be the egg donor. Confirm the medical criteria and examination protocol with the licensed clinic.

Articles 13 and 15 require the relationship between intended parent(s) and the surrogate to be governed by a written agreement notarized in the required form. A known-donor relationship is also subject to a written notarized agreement under Article 13. Do not treat a clinic intake form, messaging-app exchange, agency package, translated draft, or ordinary signature as a substitute for the statutory agreement. If any party signs through a representative, confirm authority and the notary's requirements in advance. Execute the agreement before the relevant treatment and before compensation is paid, not reconstruct it after a dispute.

Form is substantive, not cosmetic. Civil Code Article 300 states that failure to observe a required notarial form makes the transaction invalid and null and void, subject to a narrow court route where one party has performed and the other evades notarization. Articles 303–305 address invalidity and its consequences. This does not mean every disagreement makes the entire arrangement void; it means the parties should not assume an informal contract can be cured later. Have Armenian counsel and the notary confirm the exact form, signatories, attachments, translations, and timing before performance.

Compensation and medical expenses

Armenian law expressly allows the surrogate to receive monetary compensation for carrying the pregnancy and giving birth, under the terms of a contract made in advance. Article 15(11) names the healthcare institution or the intended parent(s) as possible payer(s). The cited provision does not set a figure. Do not rely on a clinic's quoted package price as the statutory amount or assume any intermediary may automatically pay in place of the parties named by law. Identify compensation separately from expense reimbursement, specify the payer and recipient, and have local counsel confirm tax and payment treatment.

Under Article 15(12), the intended parent(s) who contract with the surrogate bear all expenses related to the course of pregnancy, childbirth, and removal of complications confirmed by medical documents. The contract should explain how ordinary antenatal care, prescribed tests, medicines, hospital costs, delivery, and documented complications are approved, invoiced, and paid. It should also address unexpected or disputed expenses, supporting documents, timing, and what happens if a pregnancy ends early. Do not use a vague “all-inclusive” figure to obscure which party pays the surrogate's compensation and which party covers statutory medical expenses.

Agency and clinic: different legal roles

An agency may introduce parties, coordinate appointments, translate documents, or manage logistics, but its actual legal role must be written down. The surrogacy statute identifies the surrogate agreement and the healthcare institution's role; it does not make an agency brochure proof of eligibility, clinical authority, parentage, or government approval. In the official licensing materials, medical aid and services are licensable, while a separate licence category specifically called “surrogacy agency” was not established. That limited finding is not confirmation that every agency model is unregulated. Classify the actual services with Armenian counsel before launch or payment.

For paid coordination or consultancy, Civil Code Article 777 requires a written paid-services contract; Articles 779–780 address payment, impossibility of performance, and unilateral withdrawal. A separate agency agreement should state exactly what the agency must do, what it merely facilitates, its fee and when it is earned, which third-party costs need prior approval, the refund method if a milestone is missed, how records are delivered, and how conflicts are disclosed. Avoid language promising a guaranteed pregnancy, child handover, birth certificate, citizenship, or foreign passport. If the agency signs or pays on another person's behalf, confirm its authority and the lawful route for funds.

The clinical part is different from matchmaking. Article 11 places IVF and embryo transfer within the reproductive-medicine service category; Article 17 limits access to donor/surrogate registry information to licensed medical organisations in the relevant assisted-reproduction field. Armenia's Licensing Law lists providing medical aid and services as a licensable activity, and Government Decision No. 867 sets out licensing procedures. Before a deposit, check the legal entity's current licence, licensed service type, address, and status directly with the competent authority. A clinic website, company registration, or agency referral is not the same as a valid licence for the required service.

Drafting contracts and scheduling payments

At minimum, the notarized agreement should identify every party and capacity; the intended-parent eligibility route and any commission permission; the clinic and permitted procedures; the embryo and donor structure; each party's responsibilities; compensation and expense categories; payment dates and proof; medical information and confidentiality; how emergency costs are handled; and how the arrangement ends after failed treatment, miscarriage, a serious complication, or a party's death or incapacity. Set a process for amendments and for any mismatch between language versions. Do not leave core terms to an agency's later “standard policy” or an unsigned schedule.

Use an auditable payment schedule, not a single advance with unclear conditions. For each instalment, name the trigger, payer, recipient, currency, proof of payment, and treatment of bank fees or exchange differences. Separate the surrogate's agreed compensation from clinic invoices, agency fees, travel, and medically documented complications. Specify whether any amount is refundable when a cycle is cancelled or no pregnancy occurs, while preserving mandatory law and medical autonomy. Keep signed receipts, invoices, medical documents, and bank records. The statute authorizes contractual compensation but does not guarantee that a particular refund formula will be enforceable.

Medical autonomy, confidentiality and handover

A contract cannot safely be used to purchase control over a person's body. The reproductive-health law protects people against pressure, including coercion involving pregnancy or abortion, and recognizes decisions about medical interventions. Clinical decisions must remain within informed consent, medical standards, and applicable law. Do not draft automatic penalties for refusing a particular abortion, embryo reduction, treatment, or other intervention, or terms that purport to waive emergency care. Reproductive-health and surrogacy information is medical secret under Article 18; define who may receive updates, how data are stored and shared, and what disclosures are required by law.

Article 15 requires the surrogate to register for pregnancy care before 12 weeks of pregnancy, remain under medical supervision, follow medical advice, and look after her health. If she lives separately from the intended parent(s), she must inform them about the pregnancy's progress. Article 15(9)–(10) states that she may not refuse handover under an agreement concluded in accordance with the law and has no rights or duties toward the child from the time of handover. Article 15(14) lists DNA conditions: the surrogate is not the child's biological parent and an unmarried man is the child's biological parent. However, Government Decision No. 1395-N, as amended on 13 March 2025, and its standard agreement form describe DNA testing as confirming that at least one intended parent is the biological parent and the surrogate is not the biological mother. These provisions must be read together for the exact family structure; do not assume that the unmarried-man wording either applies to every case or can be ignored. Under the government procedure, all persons subject to testing must be present together for sampling; samples are taken within four working days after birth and results are due within four working days after sampling. If a person using assisted reproductive technologies cannot attend because of force majeure (an extraordinary and unavoidable circumstance), the child remains at the maternity institution; absent medical indications, the stay may be chargeable unless Armenian law provides otherwise. The child remains there until the result and handover. Before treatment, obtain written Armenian legal advice on the procedure, any chargeable hospital-stay costs, and the interpretation applicable to the family.

Disputes and cross-border planning

Write a route for delay, breach, refund requests, confidentiality breaches, and disagreements about expenses. Name the notices required, response periods, evidence to retain, the competent Armenian forum or agreed dispute mechanism, and whether urgent medical or child-related matters need immediate court relief. A private agency cannot decide parentage or compel a public registry to act. A payment dispute may be separate from a parentage or handover dispute, so do not make all remedies depend on one broad clause. Ask counsel to test the remedies against mandatory family, medical, and contract law.

An Armenian contract does not settle the law of every destination country. Parentage recognition, birth registration, the child's nationality, travel documents, exit permission, and entry to the intended parents' country are separate questions governed by the relevant jurisdictions and administrative authorities. Genetic connection, Armenian birth documentation, or a clinic's assurance does not by itself guarantee foreign recognition or citizenship. Before treatment, obtain written advice for the intended parents' nationality and residence countries and planned travel route, including what happens if DNA results or registration documents are delayed or disputed.

Checklist before paying

Before paying, obtain: (1) the intended parents' written eligibility analysis, including ethnicity/nationality and biological-parent status; (2) any interdepartmental commission permission; (3) the surrogate's medical/genetic screening and eligibility confirmation; (4) a verified clinic licence for reproductive medicine; (5) the complete notarized surrogate agreement and, where relevant, donor agreement; (6) a separate written agency/clinic service contract; (7) an itemised budget, staged payment terms, expense rules, refund clauses, and receipts; and (8) written cross-border parentage, nationality, registration, and travel advice. Pause if a provider refuses to disclose its legal identity, licence, contract draft, or recipient of funds.

Scope, sources

The current consolidated Armenian reproductive-health law, Civil Code and implementing rules should be checked again on the signing date. Government Decision No. 1395-N, as amended on 13 March 2025, sets the DNA-testing procedure, but its interaction with Article 15(14) should be confirmed by Armenian counsel for the specific family structure. Tax/accounting treatment, the classification of agency services and registry practice also need confirmation, as do any later amendments. The reviewed official licensing sources did not establish a separate licence category for non-medical surrogacy agencies and did not verify any specific clinic's licence; these limits do not prove that a transaction is unlawful.

Primary sources and source limits

The available English Civil Code texts are not a substitute for the current Armenian wording; counsel should check the Armenian text before signing.

  1. Official consolidated Armenian law: Human Reproductive Health and Reproductive Rights (Articles 11–19; current Armenian text, including amendments effective in December 2025)
  2. Constitutional Court of Armenia, decision SDO-1775 of 1 April 2025 (Armenian text)
  3. Civil Code of Armenia, official consolidated English-language text (amendments through 23 March 2026; verify current Armenian wording)
  4. Civil Code of Armenia, official English text (amendments through 5 March 2025; older translation for comparison)
  5. Law of Armenia on Licensing, official English text (amendments through 11 September 2025)
  6. Government Decision No. 867 on licensing medical aid and services (consolidated Armenian text)
  7. Law HO-404-N of 4 December 2025 amending Article 12(1) of the Law on Human Reproductive Health and Reproductive Rights; effective 20 December 2025 (Armenian text)
  8. Government Decision No. 1395-N of 26 October 2017 on the procedure and deadlines for DNA testing, including amendments of 13 March 2025 (Armenian text)

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards